|
|
|
|
Vol. 53, Issue 1, 23-32, January 1998
Division of Reproductive Biology, Department of Gynecology and
Obstetrics, Stanford University Medical Center, Stanford, California
94305-5317 (T.B., F.N., C.S., M.H., M.C.),
Institute of Histology and
General Embryology, University of Rome, La Sapienza, Rome 00161, Italy
(S.I., M.C.), and
Syntex Research, Palo Alto, California 94303 (E.R.S.)
To determine the properties of the cAMP-specific, rolipram-sensitive
phosphodiesterases (cAMP-PDEs) that are expressed in different organs,
monoclonal and polyclonal antibodies were raised against different
epitopes present in the cAMP-PDE sequences. Of the several antibodies
generated against peptides and fusion proteins, one monoclonal and four
polyclonal antibodies recognized both the native cAMP-PDEs as well as
the denatured proteins on Western immunoblot analysis. An
immunoprecipitation assay demonstrated that these antibodies recognized
the recombinant rat PDE4A, PDE4B, and PDE4D proteins with different
avidity. The polyclonal antibody K118 and the monoclonal M3S1 were most
specific for rat PDE4B and PDE4D forms, respectively, whereas the AC55
antiserum displayed the highest affinity for PDE4A forms. This
selectivity was confirmed by Western blot analysis using recombinant
rat PDE4A, PDE4B, and PDE4D proteins expressed in a heterologous
system. These antibodies were used to characterize the cAMP-PDEs
expressed in the rat brain. An immunoblot of extract of cortex and
cerebellum demonstrated that at least seven different polypeptides
specifically cross-reacted with the different antibodies, indicating
that multiple cAMP-PDEs are expressed in this tissue. On the basis of
cross-reactivity with PDE4D but not PDE4A or PDE4B antibodies, 93- and
105-kDa PDE4D species were detected in the cortex and cerebellum
extract. These forms are different from the 68-kDa PDE4D form expressed in endocrine cells after hormonal stimulation. Although the 93-kDa form
was recovered in both the soluble and particulate fractions, the
105-kDa polypeptide was mostly particulate in the cortex and cerebellum
extracts. PDE4B forms of 90-87 kDa were recovered in both soluble and
particulate compartments of the brain extract. These forms were
different from the previously identified PDE4A variants of 110 and 75 kDa. These data demonstrate that the presence of multiple cAMP-PDE
genes is translated into cAMP-PDE proteins of different sizes and
distinct immunological properties and that multiple variants derived
from these cAMP-PDE genes are expressed in different regions of the
brain and different subcellular compartments. These immunological tools
will be useful to identify different cAMP-PDE forms expressed in organs
targeted for pharmacological intervention with PDE4 inhibitors.
This article has been cited by other articles:
![]() |
R. Zhang, E. Maratos-Flier, and J. S. Flier Reduced Adiposity and High-Fat Diet-Induced Adipose Inflammation in Mice Deficient for Phosphodiesterase 4B Endocrinology, July 1, 2009; 150(7): 3076 - 3082. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-O. Larsen, B. Lygren, I. Sjaastad, K. A. Krobert, K. Arnkvaern, G. Florholmen, A.-K. R. Larsen, F. O. Levy, K. Tasken, O. H. Skjonsberg, et al. Diastolic dysfunction in alveolar hypoxia: a role for interleukin-18-mediated increase in protein phosphatase 2A Cardiovasc Res, October 1, 2008; 80(1): 47 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Herve, T. Schmitz, D. Evain-Brion, D. Cabrol, M.-J. Leroy, and C. Mehats The PDE4 Inhibitor Rolipram Prevents NF-{kappa}B Binding Activity and Proinflammatory Cytokine Release in Human Chorionic Cells J. Immunol., August 1, 2008; 181(3): 2196 - 2202. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Peter, S. L. C. Jin, M. Conti, A. Hatzelmann, and C. Zitt Differential Expression and Function of Phosphodiesterase 4 (PDE4) Subtypes in Human Primary CD4+ T Cells: Predominant Role of PDE4D J. Immunol., April 15, 2007; 178(8): 4820 - 4831. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lee, W. Richter, W. Namkung, K. H. Kim, E. Kim, M. Conti, and M. G. Lee Dynamic Regulation of Cystic Fibrosis Transmembrane Conductance Regulator by Competitive Interactions of Molecular Adaptors J. Biol. Chem., April 6, 2007; 282(14): 10414 - 10422. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schmitz, E. Souil, R. Herve, C. Nicco, F. Batteux, G. Germain, D. Cabrol, D. Evain-Brion, M.-J. Leroy, and C. Mehats PDE4 Inhibition Prevents Preterm Delivery Induced by an Intrauterine Inflammation J. Immunol., January 15, 2007; 178(2): 1115 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bajpai, S. E. Fiedler, Z. Huang, S. Vijayaraghavan, G. E. Olson, G. Livera, M. Conti, and D. W. Carr AKAP3 Selectively Binds PDE4A Isoforms in Bovine Spermatozoa Biol Reprod, January 1, 2006; 74(1): 109 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Barnes, G. Livera, P. Huang, C. Sun, W. K. O'Neal, M. Conti, M. J. Stutts, and S. L. Milgram Phosphodiesterase 4D Forms a cAMP Diffusion Barrier at the Apical Membrane of the Airway Epithelium J. Biol. Chem., March 4, 2005; 280(9): 7997 - 8003. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. MEHATS, S.-L. C. JIN, J. WAHLSTROM, E. LAW, D. T. UMETSU, and M. CONTI PDE4D plays a critical role in the control of airway smooth muscle contraction FASEB J, October 1, 2003; 17(13): 1831 - 1841. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. De Arcangelis, D. Coletti, M. Conti, M. Lagarde, M. Molinaro, S. Adamo, G. Nemoz, and F. Naro IGF-I-induced Differentiation of L6 Myogenic Cells Requires the Activity of cAMP-Phosphodiesterase Mol. Biol. Cell, April 1, 2003; 14(4): 1392 - 1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Richard, A. Tsafriri, and M. Conti Role of Phosphodiesterase Type 3A in Rat Oocyte Maturation Biol Reprod, November 1, 2001; 65(5): 1444 - 1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hansen, S.-L. C. Jin, D. T. Umetsu, and M. Conti Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D PNAS, June 6, 2000; 97(12): 6751 - 6756. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Herman, D. M. Juilfs, E. B. Fauman, P. Juneau, and J. P. Menetski Analysis of a Mutation in Phosphodiesterase Type 4 that Alters Both Inhibitor Activity and Nucleotide Selectivity Mol. Pharmacol., May 1, 2000; 57(5): 991 - 999. [Abstract] [Full Text] |
||||
![]() |
N. Oki, S.-I. Takahashi, H. Hidaka, and M. Conti Short Term Feedback Regulation of cAMP in FRTL-5 Thyroid Cells. ROLE OF PDE4D3 PHOSPHODIESTERASE ACTIVATION J. Biol. Chem., April 6, 2000; 275(15): 10831 - 10837. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Méhats, G. Tanguy, B. Paris, B. Robert, N. Pernin, F. Ferré, and M.-J. Leroy Pregnancy Induces a Modulation of the cAMP Phosphodiesterase 4-Conformers Ratio in Human Myometrium: Consequences for the Utero-Relaxant Effect of PDE4-Selective Inhibitors J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 817 - 823. [Abstract] [Full Text] |
||||
![]() |
F. Naro, C. Sette, E. Vicini, V. De Arcangelis, M. Grange, M. Conti, M. Lagarde, M. Molinaro, S. Adamo, and G. Némoz Involvement of Type 4 cAMP-Phosphodiesterase in the Myogenic Differentiation of L6 Cells Mol. Biol. Cell, December 1, 1999; 10(12): 4355 - 4367. [Abstract] [Full Text] |
||||
![]() |
S.-L. C. Jin, F. J. Richard, W.-P. Kuo, A. J. D'Ercole, and M. Conti Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice PNAS, October 12, 1999; 96(21): 11998 - 12003. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lim, G. Pahlke, and M. Conti Activation of the cAMP-specific Phosphodiesterase PDE4D3 by Phosphorylation. IDENTIFICATION AND FUNCTION OF AN INHIBITORY DOMAIN J. Biol. Chem., July 9, 1999; 274(28): 19677 - 19685. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Méhats, G. Tanguy, E. Dallot, B. Robert, R. Rebourcet, F. Ferré, and M. J. Leroy Selective Up-Regulation of Phosphodiesterase-4 Cyclic Adenosine 3',5'-Monophosphate (cAMP)-Specific Phosphodiesterase Variants by Elevated cAMP Content in Human Myometrial Cells in Culture Endocrinology, July 1, 1999; 140(7): 3228 - 3237. [Abstract] [Full Text] |
||||
![]() |
M. Salanova, S.-Y. Chun, S. Iona, C. Puri, M. Stefanini, and M. Conti Type 4 Cyclic Adenosine Monophosphate-Specific Phosphodiesterases Are Expressed in Discrete Subcellular Compartments during Rat Spermiogenesis Endocrinology, May 1, 1999; 140(5): 2297 - 2306. [Abstract] [Full Text] |
||||
![]() |
M. Takahashi, R. Terwilliger, C. Lane, P. S. Mezes, M. Conti, and R. S. Duman Chronic Antidepressant Administration Increases the Expression of cAMP-Specific Phosphodiesterase 4A and 4B Isoforms J. Neurosci., January 15, 1999; 19(2): 610 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. O'Connor, L. M. Shaw, and A. M. Mercurio Release of cAMP Gating by the alpha 6beta 4 Integrin Stimulates Lamellae Formation and the Chemotactic Migration of Invasive Carcinoma Cells J. Cell Biol., December 14, 1998; 143(6): 1749 - 1760. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-L. C. Jin, T. Bushnik, L. Lan, and M. Conti Subcellular Localization of Rolipram-sensitive, cAMP-specific Phosphodiesterases. DIFFERENTIAL TARGETING AND ACTIVATION OF THE SPLICING VARIANTS DERIVED FROM THE PDE4D GENE J. Biol. Chem., July 31, 1998; 273(31): 19672 - 19678. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Tasken, P. Collas, W. A. Kemmner, O. Witczak, M. Conti, and K. Tasken Phosphodiesterase 4D and Protein Kinase A Type II Constitute a Signaling Unit in the Centrosomal Area J. Biol. Chem., June 15, 2001; 276(25): 21999 - 22002. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Verde, G. Pahlke, M. Salanova, G. Zhang, S. Wang, D. Coletti, J. Onuffer, S.-L. C. Jin, and M. Conti Myomegalin Is a Novel Protein of the Golgi/Centrosome That Interacts with a Cyclic Nucleotide Phosphodiesterase J. Biol. Chem., March 30, 2001; 276(14): 11189 - 11198. [Abstract] [Full Text] [PDF] |
||||